Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Sequenom's MaterniT21 Plus; Milford Medical Lab's Lyme Disease Test


The Mayo Medical Laboratories will now offer Sequenom's MaterniT21 Plus test to patients at high risk for fetal chromosome abnormalities. The test uses next-generation sequencing to noninvasively screen for fetal aneuploidies in chromosomes 21, 18, and 13, as well as the X and Y chromosomes. It also reports some subchromosomal microdeletions and microduplications.

Milford Medical Laboratory in Connecticut is now offering a Sanger sequencing-based test for Borrelia burgdorferi and Borrelia miyamotoi, which cause Lyme disease and Lyme disease-like infection. The test sequences a target segment of the bacterial16S ribosomal RNA gene and is available for $150.